Interestingly, despite the well described pro-inflammatory effects of systemic IL-6 in obesity and metabolic diseases, clinical studies show that IL-6 secreted by contracting skeletal muscle exerts anti-inflammatory effects and promotes favourable metabolic responses, also increasing insulin sensitivity [50]. Here, IL6 is linked to obesity due to melanocortin 4 receptor deficiency.